Denali Therapeutics Inc Forecast and Target Price
$13.78
Denali Therapeutics Inc (DNLI) Share Price Forecast
Currently 23 wall-street analysts regularly analyze the financials of Denali Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Denali Therapeutics Inc (DNLI) have a share price target of $32.25. This median of share price forecast represents a 134.03% upside from the latest price of $13.78 as on 18.05.25.
Denali Therapeutics Inc (DNLI) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Denali Therapeutics Inc (DNLI) share price will touch around $32.25 in next 12-months.
Denali Therapeutics Inc (DNLI) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Denali Therapeutics Inc's share price and its median forecast price. As on 18.05.25, the difference is -50.2%
Denali Therapeutics Inc (DNLI): Difference between Current Price & Median Forecasted Price
Denali Therapeutics Inc (DNLI) Share Price : Analyst Recommendation
Based on 23 analysts tracking and researching Denali Therapeutics Inc (DNLI) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 11 | 11 | 11 |
| Outperform | 9 | 9 | 9 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |